tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Orthofix Reports Q3 2025 Financial Results

Story Highlights
Orthofix Reports Q3 2025 Financial Results

TipRanks Black Friday Sale

Orthofix ( (OFIX) ) has shared an update.

Orthofix reported its financial results for the third quarter of 2025, showing a net sales increase of 5% on a reported basis and 6% on a pro forma constant currency basis compared to the same period in 2024. Despite a net loss of $22.8 million, the company achieved a positive free cash flow of $2.5 million and expanded its adjusted EBITDA margin for the seventh consecutive quarter. The U.S. Spine Fixation segment saw an 8% growth in net sales, driven by the 7D FLASH navigation technology, while the U.S. Orthopedics business benefited from the commercial launch of TrueLok Elevate. Orthofix has narrowed its full-year 2025 net sales guidance while raising the low end of its adjusted EBITDA guidance, indicating a strong operational performance and a commitment to long-term growth.

The most recent analyst rating on (OFIX) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Orthofix stock, see the OFIX Stock Forecast page.

Spark’s Take on OFIX Stock

According to Spark, TipRanks’ AI Analyst, OFIX is a Neutral.

Orthofix’s overall score reflects strong revenue growth and positive developments in product launches, but is weighed down by profitability challenges and cash flow constraints. Technical indicators suggest neutral momentum, while valuation metrics highlight ongoing financial difficulties.

To see Spark’s full report on OFIX stock, click here.

More about Orthofix

Orthofix is a global medical technology company that specializes in spine and orthopedics products. The company is known for its spinal implants, bone growth therapies, and enabling technologies, with a focus on innovation and market leadership in the medical technology industry.

Average Trading Volume: 364,760

Technical Sentiment Signal: Buy

Current Market Cap: $634.3M

For an in-depth examination of OFIX stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1